TrialStroke2026

Liraglutide and Recurrent Stroke by Baseline Insulin Resistance: A Post Hoc Analysis of the LAMP Trial.

Longyan Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.